TXNIP and metabolic dysfunction-associated steatotic liver disease: However, the roles of the TXNIP and NLRP3 inflammasome in the progression of NAFLD are controversial and the precise mechanism underlying NLRP3 inflammasome activation through TXNIP in KCs remains to be evaluated [21].